⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Obesity Care Week 2026 Concludes with Global Momentum for Advancing Care
prnewswire.com
LLY
AMGN
REGN
NVO
BSX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
prnewswire.com
NVO
Bronstein, Gewirtz & Grossman, LLC Encourages Novo Nordisk A/S (NVO) Stockholders to Inquire about Securities Investigation
accessnewswire.com
NVO
GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026
globenewswire.com
LLY
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
prnewswire.com
BIIB
IONS
ALNY
AZN
GILD
JNJ
BMRN
VRTX
ASTL
PFE
NVO
REGN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novo Nordisk A/S (NVO) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
globenewswire.com
NVO
Novo Nordisk A/S (NVO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NVO
Drug Discovery Leader Marcus Schindler Joins Cradle's Advisory Board
prnewswire.com
JNJ
ABBV
NVO